Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optical Coherence Tomography Angiography in Neovascular Age-related Macular Degeneration

NCT02253030 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT02253030
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02253030 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optical Coherence Tomography Angiography in Neovascular Age-related Macular Degeneration
Lead sponsor
Oregon Health and Science University
Phase
Observational
Overall status
Recruiting
Start date
September 30, 2014
Completion date
December 31, 2026
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neovascular (wet) age-related macular degeneration (amd)